Turing CEO will keep high Daraprim price for individuals
There is more controversy over prescription drug prices and Turing Pharmaceuticals CEO Martin Shkreli. Shkreli caused a public uproar when he drastically raised the price of a lifesaving drug for cancer and AIDS patients. He promised to cut the cost, but that was two months ago. Now he's saying he will reduce the price for hospitals only, not individuals. Don Dahler reports.
▶︎
Turing CEO Martin Shkreli Talks 5,000% Drug Price Hike (Full Interview) | CNBC
▶︎
He Played the Most Evil Man in America. Was He Really?
▶︎
Shkreli: Price Increase Has Stuck, Happy With That
▶︎
Steve Miller Asks if I Know Fleetwood Mac and This Waitress Steals The Show
▶︎
American Greed: CNBC Interviews Martin Shkreli About The Daraprim Price Hike | CNBC Prime
▶︎
マーティン･シュクレリが暴く 製薬会社のカラクリ
▶︎
Golden Retriever Meets Completely Broken Rescue for the First Time
▶︎
Pharma Bro Martin Shkreli Laughs as $1/Pill Alternative to Daraprim Surfaces
▶︎
CEO defends raising drug price 5,000 percent
▶︎
Prince Auditions - SNL
▶︎
The Most Legendary Opening Credits Ever | SNATCH
▶︎
Sacha 'Borat' Baron Cohen Asks Melanie "What Her Price Is" | Friday Night With Jonathan Ross
▶︎
LAWYER: If Cops Say "I Smell Alcohol" - Say THESE WORDS
▶︎
Turing Pharmaceuticals CEO defends Daraprim price hike
▶︎
How The Rothschilds Outplayed Hitler
▶︎
‘We have never seen anything on this scale’: Haberman on Trump financial disclosures
▶︎
160 KG VILLAGE MONSTER - The ANOMALY Nobody Can Explain - SUPERHUMAN ANDREY SMAEV
▶︎
Martin Shkreli Congressional Hearing: Pharma CEO's Greatest Moments | CNBC
▶︎
Martin Shkreli must return $64M from Daraprim price hike | Top 10
▶︎